國立高雄大學圖資館 |

Language: English

Back

Bile acids and their receptors

Distrutti, Eleonora.

Bile acids and their receptors

Record Type:	Electronic resources : Monograph/item
Title/Author:	Bile acids and their receptorsedited by Stefano Fiorucci, Eleonora Distrutti.
other author:	Fiorucci, Stefano.
Published:	Cham :Springer International Publishing :2019.
Description:	x, 378 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Bile acids.
Online resource:	https://doi.org/10.1007/978-3-030-22005-1
ISBN:	9783030220051$q(electronic bk.)

Bile acids and their receptors
Bile acids and their receptors[electronic resource] /edited by Stefano Fiorucci, Eleonora Distrutti. - Cham :Springer International Publishing :2019. - x, 378 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2560171-2004 ;. - Handbook of experimental pharmacology ;208..

Preface -- Part 1. Bile acids as signaling molecules and their receptors -- 1. A short history of bile acid pharmacology -- 2. Bile acids activated receptors: a review of GPBAR1 (TGR5) and other G-protein-coupled receptors -- 3. Bile acid activated receptors: a review of FXR and other Nuclear receptors -- 4. The intestinal enterokine fibroblast growth factor 15/19 in bile acid metabolism -- 5. Signaling from intestine to the host. How bile acids regulate intestinal and liver immunity -- Part 2. General pharmacology of bile acid activated receptors and their ligands -- 6. Modeling of bile acid activated receptors as a tool for pharmacological development -- 7. Chemistry and pharmacology of GPBAR1 and FXR selective agonists, dual agonists and antagonists -- 8. Non steroidal FXR ligands: current status and clinical applications -- 9. Intestinal selective FXR agonists and their potential in treating liver and metabolic diseases -- Part 3. Bile acids and their derivatives as drugs -- 10. UDCA, Nor-UDCA and T-UDCA: a review of their mechanisms of action and clinical applications -- 11. Chenodeoxycholic acid: an update on its therapeutic appplications and safety profile -- 12. Obeticholic acid: a review of its mechanisms of action and clinical applications -- Part 4. Bile acid activated receptors as therapeutic targets -- 13. Targeting FXR in cholestasis -- 14. FXR agonists for the treatment of NASH and other metabolic disorders -- 15. Targeting bile acids activated receptors in bariatric surgery.

This book focusses on the latest results related to the field of bile acids as signaling molecules and describes how these receptors have become a major pharmacological target. It covers all major areas of research in this field, from genetics, chemistry, in silico modeling, molecular biology to clinical applications, offering a cross-country view of the functional role of bile acids as signaling molecules, virtually acting on all major areas of metabolism. While FXR and GPBAR1 are essential bile acid sensors that integrate the de novo bile acid synthesis with intestinal microbiota and liver metabolism, in a broader sense, BARs play a pathogenic role in the development of common human alignments including liver, intestinal and metabolic disorders, such as steatosis (NAFLD) and steato-hepatitis (NASH), diabetes, obesity and atherosclerosis.

ISBN: 9783030220051$q(electronic bk.)

Standard No.: 10.1007/978-3-030-22005-1doiSubjects--Topical Terms:

780069
Bile acids.

LC Class. No.: QP752.B54 / B554 2019

Dewey Class. No.: 612.35

Bile acids and their receptors
LDR:03432nmm a2200337 a 4500 001 586602
003 DE-He213
005 20200903153931.0
006 m d
007 cr nn 008maaau
008 210326s2019 sz s 0 eng d
020 $a 9783030220051$q(electronic bk.)
020 $a 9783030220044$q(paper)
024 7 $a 10.1007/978-3-030-22005-1 $2 doi
035 $a 978-3-030-22005-1
040 $a GP $c GP
041 0 $a eng
050 4 $a QP752.B54 $b B554 2019
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 612.35 $2 23
090 $a QP752.B54 $b B595 2019
245 0 0 $a Bile acids and their receptors $h [electronic resource] / $c edited by Stefano Fiorucci, Eleonora Distrutti.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a x, 378 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.256
505 0 $a Preface -- Part 1. Bile acids as signaling molecules and their receptors -- 1. A short history of bile acid pharmacology -- 2. Bile acids activated receptors: a review of GPBAR1 (TGR5) and other G-protein-coupled receptors -- 3. Bile acid activated receptors: a review of FXR and other Nuclear receptors -- 4. The intestinal enterokine fibroblast growth factor 15/19 in bile acid metabolism -- 5. Signaling from intestine to the host. How bile acids regulate intestinal and liver immunity -- Part 2. General pharmacology of bile acid activated receptors and their ligands -- 6. Modeling of bile acid activated receptors as a tool for pharmacological development -- 7. Chemistry and pharmacology of GPBAR1 and FXR selective agonists, dual agonists and antagonists -- 8. Non steroidal FXR ligands: current status and clinical applications -- 9. Intestinal selective FXR agonists and their potential in treating liver and metabolic diseases -- Part 3. Bile acids and their derivatives as drugs -- 10. UDCA, Nor-UDCA and T-UDCA: a review of their mechanisms of action and clinical applications -- 11. Chenodeoxycholic acid: an update on its therapeutic appplications and safety profile -- 12. Obeticholic acid: a review of its mechanisms of action and clinical applications -- Part 4. Bile acid activated receptors as therapeutic targets -- 13. Targeting FXR in cholestasis -- 14. FXR agonists for the treatment of NASH and other metabolic disorders -- 15. Targeting bile acids activated receptors in bariatric surgery.
520 $a This book focusses on the latest results related to the field of bile acids as signaling molecules and describes how these receptors have become a major pharmacological target. It covers all major areas of research in this field, from genetics, chemistry, in silico modeling, molecular biology to clinical applications, offering a cross-country view of the functional role of bile acids as signaling molecules, virtually acting on all major areas of metabolism. While FXR and GPBAR1 are essential bile acid sensors that integrate the de novo bile acid synthesis with intestinal microbiota and liver metabolism, in a broader sense, BARs play a pathogenic role in the development of common human alignments including liver, intestinal and metabolic disorders, such as steatosis (NAFLD) and steato-hepatitis (NASH), diabetes, obesity and atherosclerosis.
650 0 $a Bile acids. $3 780069
650 1 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Gastroenterology. $3 274091
650 2 4 $a Hepatology. $3 274979
650 2 4 $a Endocrinology. $3 196517
700 1 $a Fiorucci, Stefano. $3 878135
700 1 $a Distrutti, Eleonora. $3 878136
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 559421
856 4 0 $u https://doi.org/10.1007/978-3-030-22005-1
950 $a Biomedical and Life Sciences (SpringerNature-11642)